Showing results (171-180 of 242) with videos related to

Sort By:
Pageof 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II trial of intraperitoneal cisplatin and etoposide as salvage treatment for minimal residual ovarian carcinomaS Kirmani, W E Lucas, S Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60E Kimura, R E Enns, J E Alcaraz, et al.
Cancer Research|December 15, 1992
Modulation of cisplatin resistance in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.
Biochemical Pharmacology|March 23, 1999
Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cellsK V Ferry, D Fink, S W Johnson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 20, 2004
Improved targeting of platinum chemotherapeutics. the antitumour activity of the HPMA copolymer platinum agent AP5280 in murine tumour modelsX Lin, Q Zhang, J R Rice, et al.
Obstetrics and Gynecology|May 1, 1993
Profiles of women age 30-39 and age less than 30 with epithelial ovarian cancerS C Plaxe, P S Braly, J L Freddo, et al.
Gynecologic Oncology|June 1, 1993
High-dose biweekly intraperitoneal cisplatin: an effective way to increase cisplatin dose intensityA Bonetti, S B Howell, E McClay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Dose intensification of cisplatin chemotherapy through biweekly administrationS Kim, S B Howell, E McClay, et al.
Pageof 25